期刊文献+

耐甲氧西林金黄色葡萄球菌诱导SKH-1无毛小鼠菌血症模型 被引量:4

Establishment of a SKH-1 hairless mouse model of bacteraemia induced by MRSA infection
在线阅读 下载PDF
导出
摘要 目的建立SKH-1无毛小鼠感染MRSA致菌血症模型的方法及其评价体系。方法 62只SPF级SKH-1无毛小鼠随机分成PBS对照组、低剂量模型组、高剂量模型组及给药组,尾静脉注射无菌PBS至对照组小鼠体内,其余各组小鼠尾静脉注射相应剂量MRSA(ST-239)菌悬液,从体重、死亡率、血常规、血液细菌浓度、主要器官荷菌量及病理改变等方面对模型进行评价,并用抗生素替考拉宁对模型进行检验。结果各组感染小鼠体重均下降明显,血常规指标改变明显;高剂量组死亡率高,血液中细菌浓度较高,肝、肾等多组织器官播散严重,皮肤可见多发性脓肿灶;使用替考拉宁能显著降低小鼠死亡率,减轻主要器官的损伤程度。结论应用MRSA菌株可成功诱导建立SKH-1无毛小鼠菌血症模型,模型具有病理特征明显及观察简便的优点,为相关药物评价研究提供了一个理想的动物模型。 Objective To establish a mouse model of bacteraemia infected with methicillin resistant Staphylococcus aureus(MRSA) and its evaluation system.Methods Sixty-two specific pathogen free SKH-1 hairless mice were randomly divided into 4 groups: the PBS,low-dose infection,high-dose infection and drug-treated infection groups.Mice were challenged with MRSA(ST-239) by intravenous tail injection.The bacteraemia models were evaluated by body weight,mortality,blood tests,blood bacterial concentrations,organs infection measuring and pathological examination,and the models were also verified with antibiotic teicoplanin.Results The infected mice had evident weight loss,high mortality,sharp changes in blood tests,high bacterial concentration in the blood and pathological alterations in many organs sush as in the liver and kidney.Teicoplanin reduced the mortality markedly and alleviated lesions of organs.Conclusions A SKH-1 hairless mouse model of bacteraemia has been successfully established by MRSA infection.This mouse model has apparent pathological features,is easy to be observed,and provides an ideal animal model for MRSA-related drugs evaluation studies.
出处 《中国实验动物学报》 CAS CSCD 2011年第6期512-516,I0003,共6页 Acta Laboratorium Animalis Scientia Sinica
基金 上海市科技发展基金项目(编号:09140900700)
关键词 耐甲氧西林金黄色葡萄球菌 菌血症 模型 SKH-1无毛小鼠 methicillin resistant Staphylococcus aureus MRSA Bacteraemia Model SKH-1 hairless mice
  • 相关文献

参考文献12

  • 1Nickerson EK,West TE,Day NP,et al,Staphylococcus augus disease and drug resistance in resource-limited countries in south and east Asia[J].Lancet Infect Dis,2009,9(2):130-135.
  • 2汪复,朱德妹,胡付品,阮斐怡,倪语星,孙景勇,徐英春,张小江,胡云健,艾效曼,俞云松,杨青,孙自镛,李丽,贾蓓,黄文祥,卓超,苏丹虹,魏莲花,吴玲,张朝霞,季萍,王传清,薛建昌,张泓,李万华,徐元宏,沈继录,单斌,杜艳.2009年中国CHINET细菌耐药性监测[J].中国感染与化疗杂志,2010,10(5):325-334. 被引量:397
  • 3CDC.Staphylococcus aureus resistant to vancomycin--United States[J].J Am Med Assoc,2002,288 (7):824-825.
  • 4Kokai-Kun JF,Chanturiva T Mond JJ.Lysostaphin as a treatment for systemic Staphyloccus aureus infection in a mouse model[J].J Antimicrob Chemother,2007,60(5):1051-1059.
  • 5Brakstad OG,Aasbakk K,Maeland JA.Detec/ion of Staphylococcus aureus by polymerase chain reaction amplification of the nuc gene[J].J Clin Microbiol,1992,30(7):1654-1660.
  • 6Lim TT,Coombs GW,Grubb WB.Genetic organization of mecA and mecA-regulatory genes in epidemic methicillin-resistant Staphylococcus aureus from Australia and England[J].J A nlimicrob Chemother,2002,50(6):819-824,.
  • 7Louie L,Matsumura SO,Choi E,et al.Evaluation of three rapid methods for detection of methicillin resistance in Staphylococcus aureus[J].J Clin Microbiol,2000,38(6):2170-2173.
  • 8Rodvold KA,Nicolau DP,Lodise TP,et al.Identifying exposure targets for treatment of Staphylococcal pneumonia with ceftobiprole[J].Antimicrob Agents Chemother,2009,53 (8):3294-3301,.
  • 9Wolkewitz M,Frank U,Philips G,et al.Mortality associated with in-hospital bacteraemia caused by Staphylocccus aureus:a multistate analysis with follow-up beyond hospital discharge[J].J Antimicrob Chemother,2011,66 (2):381-386.
  • 10Hidayat LK,Hsu D,Quist R,et al.High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections:efficacy and toxicity[J].Arch Intern Med,2006,166(19):2138-2144.

二级参考文献42

  • 1Grundmann H,Aires-de-Sousa M,Boyce J,et al.Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a publichealth threat.Lancet,2006,368(9538):874-885.
  • 2Daum RS,Seal JB.Evolving antimicrobial chemotherapy for Staphylococcus aureus infections:Our backs to the wall.Crit Care Med,2001,29(4 Suppl):N92-96.
  • 3Maltezou HC,Giamarellou H.Community-acquired methicillin-resistant Staphylococcus aureus infections.Int J Antimicrob Agents,2006,27(2):87-96.
  • 4Otter JA,French GL.Nosocomial transmission of community-associated methicillin-resistant Staphylococcus aureus:an emerging threat.Lancet Infect Dis,2006,6(12):753-755.
  • 5Goldstein EJ,Citron DM,Warren YA,et al.Virulence characteristics of community-associated Staphylococcus aureus and in vitro activities of moxifloxacin alone and in combination against community-associated and healthcare-associated meticillin-resistant and susceptible S.aureus.J Med Microbiol,2008,57 (Pt 4):452-456.
  • 6Adedeji A,Gray JW.MRSA at an English children's hospital from 1998 to 2003.Arch Dis Child,2005,90(7):720-723.
  • 7Faria NA,Oliveira DC,Westh H,et al.Epidemiology of emerging methicillin-resistant Staphylococcus aureus (MRSA) in Denmark:a nationwide study in a country with low prevalence of MRSA infection.J Clin Microbiol,2005,43(4):1836-1842.
  • 8Haddadin AS,Fappiano SA,Lipsett PA.Methicillin resistant Staphylococcus aureus (MRSA) in the intensive care unit.Postgrad Med J,2002,78(921):385-392.
  • 9Sax H,Harbarth S,Gavazzi G,et al.Prevalence and prediction of previously unknown MRSA carriage on admission to a geriatric hospital.Age Ageing,2005,34(5):456-462.
  • 10Smith NP,Nelson MR,Azadian B,et al.An outbreak of methicillin-resistant Staphylococcus aureus (MRSA) infection in HIVseropositive persons.Int J STD AIDS,1998,9(12):726-730.

共引文献399

同被引文献34

  • 1徐艳,曹松屹,曲格霆.大黄抑菌作用的体外研究[J].中国中医药信息杂志,2007,14(2):43-44. 被引量:23
  • 2李云飞,赵明东,戴文达,董健,王惠生,罗苹.兔耐甲氧西林金黄色葡萄球菌慢性骨髓炎模型[J].中华实验外科杂志,2007,24(4):503-504. 被引量:14
  • 3苟奎斌,孙丽华,娄卫宁,冷传刚,王炎.大黄中4种蒽醌类化合物抑幽门螺杆菌效果比较[J].中国药学杂志,1997,32(5):278-280. 被引量:58
  • 4LiM,DuX,Villaruz A E. MRSA epidemic linked to a quickly spreading colonization and virulence determinant[J].{H}Nature Medicine,2012,(05):816-819.
  • 5Kinoshita M,Miyazaki H,Ono S. Enhancement of neutrophil function by interleukin-18 therapy protects burn-injured mice from methicillin-resistant Staphylococcus aureus[J].{H}Infection and Immunity,2011,(07):2670-2680.
  • 6Dansby W,Purdue G,Hunt J. Aerosolization of methicillin-resistant Staphylococcus aureus during an epidemic in a burn intensive care unit[J].{H}JOURNAL OF BURN CARE & RESEARCH,2008,(02):331-337.
  • 7Kokai-Kun JF,Chanturiya T,Mond JJ. Lysostaphin as a treatment for systemic Staphylococcus aureus infection in a mouse model[J].{H}Journal of Antimicrobial Chemotherapy,2007,(05):1051-1059.
  • 8Martinez-Hernandez E,Horvath J,Shiloh-Malawsky Y. Analysis of complement and plasma cells in the brain of patients with anti-NMDAR encephalitis[J].{H}NEUROLOGY,2011,(06):589-593.
  • 9Louie L,Matsumura SO,Choi E. Evaluation of three rapid methods for detection of methicillin resistance in Staphylococcus aureus[J].{H}Journal of Clinical Microbiology,2000,(06):2170-2173.
  • 10Fang H,Hedin G. Rapid screening and identification of methieillin-resistant Staphylococcus aureus from clinical samples by selective-broth and real-time PCR assay[J].{H}Journal of Clinical Microbiology,2003,(07):2894-2899.

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部